These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 35213273)
21. microRNA-124-3p inhibits tumourigenesis by targeting mitogen-activated protein kinase 4 in papillary thyroid carcinoma. Sun Y; Zhang L; Zhang S Cell Biochem Funct; 2020 Dec; 38(8):1017-1024. PubMed ID: 32495394 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways. Wang Y; Liu BG; Zhou CX Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5863-5873. PubMed ID: 31298337 [TBL] [Abstract][Full Text] [Related]
23. A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3. Feng J; Zhou Q; Yi H; Ma S; Li D; Xu Y; Wang J; Yin S Cell Death Dis; 2019 Jun; 10(6):433. PubMed ID: 31160577 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-1271 inhibits the progression of papillary thyroid carcinoma by targeting IRS1 and inactivating AKT pathway. Chen Y; Hao SA; Jiang Y; Gao B; Tian WG; Zhang S; Guo LJ; Wang LL; Luo DL Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7989-7999. PubMed ID: 31599424 [TBL] [Abstract][Full Text] [Related]
25. miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1. Han J; Zhang M; Nie C; Jia J; Wang F; Yu J; Bi W; Liu B; Sheng R; He G; Kong L; Zheng L; Pang R; Ding Z; Chen L; Guan Q; Pan S; Meng X; Xu J; Liu L; Zhang J Cell Death Dis; 2019 Feb; 10(3):195. PubMed ID: 30814512 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-200c-3p Negatively Regulates ATP2A2 and Promotes the Progression of Papillary Thyroid Carcinoma. Feng YL; Ke T; Wang GL; Qi HY; Xiao Y Biochem Genet; 2022 Oct; 60(5):1676-1694. PubMed ID: 35079913 [TBL] [Abstract][Full Text] [Related]
28. Circular RNA hsa_circ_0001666 sponges miR‑330‑5p, miR‑193a‑5p and miR‑326, and promotes papillary thyroid carcinoma progression via upregulation of ETV4. Qi Y; He J; Zhang Y; Wang L; Yu Y; Yao B; Tian Z Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760216 [TBL] [Abstract][Full Text] [Related]
29. Circular RNA circ_0008274 enhances the malignant progression of papillary thyroid carcinoma via modulating solute carrier family 7 member 11 by sponging miR-154-3p. Ma J; Kan Z Endocr J; 2021 May; 68(5):543-552. PubMed ID: 33473055 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells. Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698 [TBL] [Abstract][Full Text] [Related]
31. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2. Xue KC; Hu DD; Zhao L; Li N; Shen HY Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989 [TBL] [Abstract][Full Text] [Related]
32. circRPS28 (hsa_circ_0049055) is a novel contributor for papillary thyroid carcinoma by regulating cell growth and motility via functioning as ceRNA for miR-345-5p to regulate frizzled family receptor 8 (FZD8). Mao Y; Huo Y; Li J; Zhao Y; Wang Y; Sun L; Kang Z Endocr J; 2021 Nov; 68(11):1267-1281. PubMed ID: 34108309 [TBL] [Abstract][Full Text] [Related]
33. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway. Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-26a suppresses the malignant biological behaviors of papillary thyroid carcinoma by targeting ROCK1 and regulating PI3K/AKT signaling pathway. Wu YC; Li SY; Jia YF Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8940-8949. PubMed ID: 31696481 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-23a inhibits the growth of papillary thyroid carcinoma via regulating cyclin G1. Yin JJ; Cheng XY Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3431-3439. PubMed ID: 31081097 [TBL] [Abstract][Full Text] [Related]
36. Circular RNA circLIFR suppresses papillary thyroid cancer progression by modulating the miR-429/TIMP2 axis. Zhang F; Li J; Xu J; Jiang X; Chen S; Nasser QA J Cancer Res Clin Oncol; 2024 Jun; 150(6):323. PubMed ID: 38914806 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-384 Inhibits the Progression of Papillary Thyroid Cancer by Targeting PRKACB. Wang Y; Wang B; Zhou H; Zhang X; Qian X; Cui J Biomed Res Int; 2020; 2020():4983420. PubMed ID: 31998791 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA-1266 suppresses papillary thyroid carcinoma cell metastasis and growth via targeting FGFR2. Fu YT; Zheng HB; Zhang DQ; Zhou L; Sun H Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3430-3438. PubMed ID: 29917195 [TBL] [Abstract][Full Text] [Related]
39. circFAT1(e2) Promotes Papillary Thyroid Cancer Proliferation, Migration, and Invasion via the miRNA-873/ZEB1 Axis. Liu J; Li H; Wei C; Ding J; Lu J; Pan G; Mao A Comput Math Methods Med; 2020; 2020():1459368. PubMed ID: 33133224 [TBL] [Abstract][Full Text] [Related]
40. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis. Pang R; Yang S Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]